How do you choose between resmetirom and semaglutide in the treatment of MASH?
Answer from: at Academic Institution
I write a disclaimer to start, because use of resmetirom ($5,000 per month) and semaglutide ($1,600 per month) at this time cannot be used across the board with any patient with hepatic steatosis. It's important to highlight how we characterize a patient's metabolic dysfunction associated steatotic ...
Comments
at Sovah Physician Practices Learned a lot from this. However, difficult to obt...
Learned a lot from this. However, difficult to obt...